Source:http://linkedlifedata.com/resource/pubmed/id/15156478
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
2004-5-24
|
pubmed:abstractText |
To examine risk factors for early-onset ventilator-associated pneumonia (EOP) in patients requiring mechanical ventilation (MV), we performed a prospective cohort study that included 747 patients. Pneumonia was defined as a positive result for a protected quantitative distal sample. EOP was defined as pneumonia that occurred from day 3 to day 7 of MV. Eighty patients (10.7%) experienced EOP. Independent predictors of EOP were male sex (odds ratio [OR], 2.06; 95% confidence interval [CI], 1.18-3.63), actual Glasgow Coma Scale value of 6-13 (OR, 1.95; 95% CI, 1.2-3.18), high Logistic Organ Dysfunction score at day 2 (OR, 1.12 per point; 95% CI, 1.02-1.23), unplanned extubation (OR, 3.19; 95% CI, 1.28-7.92), and sucralfate use (OR, 1.81; 95% CI, 1.01-3.26). Protection occurred with use of aminoglycosides (OR, 0.36; 95% CI, 0.17-0.76), beta -lactams and/or beta -lactamase inhibitors (OR, 0.47; 95% CI, 0.28-0.83), or third-generation cephalosporins (OR, 0.33; 95% CI, 0.16-0.74). Sucralfate use and unplanned extubation are independent risk factors for EOP. Use of aminoglycosides, beta-lactams/ beta-lactamase inhibitors, or third-generation cephalosporins protects against EOP.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1537-6591
|
pubmed:author |
pubmed-author:AzoulayEE,
pubmed-author:BornstainCC,
pubmed-author:CohenYY,
pubmed-author:CostaM AMA,
pubmed-author:De LassenceAA,
pubmed-author:Descorps-DeclereAA,
pubmed-author:Garrouste-OrgeasMM,
pubmed-author:MourvillierBB,
pubmed-author:Outcomerea Study Group,
pubmed-author:SchlemmerBB,
pubmed-author:ThuongMM,
pubmed-author:TimsitJ-FJF
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
38
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1401-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15156478-Aged,
pubmed-meshheading:15156478-Anti-Bacterial Agents,
pubmed-meshheading:15156478-Cohort Studies,
pubmed-meshheading:15156478-Female,
pubmed-meshheading:15156478-Humans,
pubmed-meshheading:15156478-Male,
pubmed-meshheading:15156478-Middle Aged,
pubmed-meshheading:15156478-Pneumonia, Bacterial,
pubmed-meshheading:15156478-Prospective Studies,
pubmed-meshheading:15156478-Respiration, Artificial,
pubmed-meshheading:15156478-Risk Factors,
pubmed-meshheading:15156478-Sucralfate,
pubmed-meshheading:15156478-Time Factors,
pubmed-meshheading:15156478-Ventilators, Mechanical
|
pubmed:year |
2004
|
pubmed:articleTitle |
Sedation, sucralfate, and antibiotic use are potential means for protection against early-onset ventilator-associated pneumonia.
|
pubmed:affiliation |
Medical ICU, Saint-Louis Hospital, 75010 Paris, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|